The Pulmonary Hypertension Association (PHA) Scientific Sessions Planning Committee has announced Norman Stockbridge, M.D., Ph.D., director of the Division of Cardiovascular and Renal Products (DCaRP) in the Center for Drug Evaluation and Research of the Food and Drug Administration (FDA), as a speaker at PHA’s 2018 International PH Conference and Scientific Sessions. DCaRP is responsible for the regulatory management of drugs and biologics used to treat PH from the point when a product is ready for human trials, through marketing approval and for as long as it remains on the market.
During his session, “What the FDA Wants for New PH Therapy Development and Approval,” Dr. Stockbridge will provide a summary of the basis for the approval of existing pulmonary arterial hypertension (PAH) therapies, and then describe how future development programs might be different. He also will address the issue with only one FDA-approved drug for the treatment of PAH in pediatric patients in the U.S. This session is intended to spur conversation about drug development and approval from a different perspective than that of treating clinicians, leaving participants with renewed motivation and ideas to facilitate the creation of new therapies in both adult and pediatric PH patients.
PHA’s 2018 International PH Conference and Scientific Sessions, the largest international gathering of PH community members in the world, will bring together nearly 500 PH-treating health care professionals to exchange knowledge and connect on advancements made in the field of PH. The theme of this year’s Scientific and Clinical Sessions is “The Path to Precision Medicine in Pulmonary Vascular Disease.” PHA is offering 20 accredited continuing education sessions aligned with this theme and participants can earn up to 16 hours of CME/CE credit. For the first time, CME/CE credit also will be available for participation in the abstract poster session on Thursday, June 28, which will include lightning-round presentations of the top submitted abstracts.
Don’t miss Dr. Stockbridge’s session. Onsite registration for PHA’s 2018 International PH Conference and Scientific Sessions in Orlando, Fla., begins June 28. More information about the Conference, June 29 to July 1, is available at www.PHAssociation.org/Conference.
Norman Stockbridge, M.D., Ph.D.